Etoglucid
Chemical compound
- L01AG01 (WHO)
- 2-[12-(oxiran-2-yl)-2,5,8,11-tetraoxadodecan-1-yl]oxirane
- 1954-28-5 Y
- 16058
- 15246 N
- 4F9KUA0T4D
- D07256 Y
- ChEMBL460287 N
- DTXSID80862800
- Interactive image
- O(CCOCCOCC1OC1)CCOCC2OC2
InChI
- InChI=1S/C12H22O6/c1(13-3-5-15-7-11-9-17-11)2-14-4-6-16-8-12-10-18-12/h11-12H,1-10H2 N
- Key:UMILHIMHKXVDGH-UHFFFAOYSA-N N
Etoglucid is a drug used in chemotherapy.[1] It is an epoxide compound.[2]
References
- ^ Flamm J, Donner G, Bucher A, Höltl W, Albrecht W, Havelec L (March 1994). "[Topical immunotherapy (KLH) vs. chemotherapy (Ethoglucid) in prevention of recurrence of superficial bladder cancer. A prospective randomized study]". Urologe A (in German). 33 (2): 138–43. PMID 8178408.
- ^ PubChem. "Etoglucid". pubchem.ncbi.nlm.nih.gov. Retrieved 2021-03-02.
- v
- t
- e
Intracellular chemotherapeutic agents / antineoplastic agents (L01)
(M phase)
Block microtubule assembly | |
---|---|
Block microtubule disassembly |
inhibitor
DNA precursors/ antimetabolites (S phase) |
| ||||||||
---|---|---|---|---|---|---|---|---|---|
Topoisomerase inhibitors (S phase) |
| ||||||||
Crosslinking of DNA (CCNS) |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e